Christopher Danes, PhD, discusses how discrete choice experiment data reveal key differences in patient and caregiver treatment preferences for ALK-positive (ALK+) non–small cell lung cancer (NSCLC) and how pharmacists can use these insights to guide shared decision-making, optimize supportive care, and personalize adherence strategies.
Frequent reassessments of therapy regimens address polypharmacy, particularly for older patients.
Concepts could be used in payer-pharmacy value-based arrangements.
Shaji Kumar, MD, shares data and insights from the phase 2 RedirecTT-1 study.
Research shows receipt of medications for chronic conditions was relatively stable in the first 2 years of the pandemic from 2020 to 2021 across racial and ethnic groups.
ADHD Awareness Months brings attention to a common, but still somewhat misunderstood condition that pharmacists encounter on a near daily basis.
Pharmacists can help address the significant asthma health disparities among racial, ethnic, and socioeconomic groups to help improve outcomes.
CagriSema is a subcutaneous injectable combination of cagrilintide and semaglutide that is currently in phase 3 trials.
Pharmacists will play a significant role in TKI adherence rates among patients.
Community pharmacists are uniquely positioned to assist with diabetes management using CGM devices.
CGM enhances diabetes management in pregnancy, improving outcomes.
Historically, colchicine has been used primarily in the management of gout; however, in 2023, the FDA approved Lodoco, a newly marketed colchicine product, for the management of cardiovascular disease.
With the vast number of drugs that can induce photosensitivity, patients taking any of these medications should receive safety counseling, especially during the summer months.
Antimicrobial stewardship efforts focusing on accurate penicillin allergy histories, β-lactam cross-reactivity education, and guideline-driven narrow-spectrum prescribing may help sustainably decrease health care–associated Clostridioides difficile infection rates.
Pharmacists will play a significant role in TKI adherence rates among patients.
Interested individuals may gain certification or continuing-education credits, many of which are available through the American College of Veterinary Pharmacists.
Data have shown the potential for the therapy to treat several new conditions.
Pharmacists play a critical role in preventing medication ordering errors during residency onboarding through proactive training, system safeguards, and interdisciplinary collaboration.
Panelists discuss how the patient journey with tardive dyskinesia involves evolving awareness and management of symptoms alongside underlying psychiatric conditions, highlighting the distinct needs of younger vs older patients and the essential role of pharmacists in supporting individualized, function-focused care throughout the lifespan.
Understanding differences in the various levodopa formulations and assisting with medication therapy management is a crucial role for pharmacists.
BRAF V600E inhibitors show improved outcomes in relapsed/refractory hairy cell leukemia.
Pharmacists are an important part of the care team for patients with bleeding disorders, providing services such as medication counseling and reconciliation.
A collaborative exercise with 16 health care organizations nets millions in savings.
Pharmacists should be aware of current discussions, attempted fixes, and expected length of drug shortages.
Historically, colchicine has been used primarily in the management of gout; however, in 2023, the FDA approved Lodoco, a newly marketed colchicine product, for the management of cardiovascular disease.
The Covid-19 pandemic has elevated telehealth as a viable alternative to face-to-face interactions under certain circumstances, the list of which is expanding as technology expands and clinicians become more accustomed to and adept in its use.
Tapping techs as immunizers opens up greater visibility and new source of health care labor.
A panel of experts comment on new therapeutic agents being developed and discuss their final thoughts on dry eye disease.
The incidence of vancomycin-resistant enterococci has nearly doubled in recent years.